Evidence map›Paper›PMID 28713774›Full record

ReviewFrontiers in cellular and infection microbiology2017

Epic Immune Battles of History: Neutrophils vs.

Fermin E Guerra, Timothy R Borgogna, Delisha M Patel, Eli W Sward, Jovanka M Voyich

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. iScience · 2026
    Article
  5. Review
  6. Host-driven remodelling of theMicrobiology (Reading, England) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Base excision repair inFrontiers in microbiology · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Lung surfactant reducesMicrobiology spectrum · 2025
    Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fermin E GuerraDepartment of Microbiology and Immunology, Montana State UniversityBozeman, MT, United States.
Timothy R BorgognaDepartment of Microbiology and Immunology, Montana State UniversityBozeman, MT, United States.
Delisha M PatelDepartment of Microbiology and Immunology, Montana State UniversityBozeman, MT, United States.
Eli W SwardDepartment of Microbiology and Immunology, Montana State UniversityBozeman, MT, United States.
Jovanka M VoyichDepartment of Microbiology and Immunology, Montana State UniversityBozeman, MT, United States.
Montana State University · US

Funding

VIRUSES: FROM PARTICLES TO PROTEOMICSP20RR020185 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI MEISSNER, NICOLE · 2004 to 2011
$17.0M
NCRR NIH HHS P20 RR020185
6 · The paper itself

Abstract

Neutrophils are the most abundant leukocytes in human blood and the first line of defense after bacteria have breached the epithelial barriers. After migration to a site of infection, neutrophils engage and expose invading microorganisms to antimicrobial peptides and proteins, as well as reactive oxygen species, as part of their bactericidal arsenal. Ideally, neutrophils ingest bacteria to prevent damage to surrounding cells and tissues, kill invading microorganisms with antimicrobial mechanisms, undergo programmed cell death to minimize inflammation, and are cleared away by macrophages.

Indexed as

Host-Pathogen InteractionsAnti-Infective AgentsBacterial AdhesionBacterial CapsulesBacterial ProteinsChemotaxisCysteine EndopeptidasesHumansImmune EvasionImmunity, InnateImmunoglobulinsInflammationMacrophagesNeutrophilsPhagocytosisReactive Oxygen SpeciesAnti-Infective AgentsBacterial Proteinschemotaxis inhibitory protein, Staphylococcus aureusCysteine EndopeptidasesFPRL1 inhibitory protein, S aureusImmunoglobulinsReactive Oxygen SpeciesSSL5 protein, Staphylococcus aureusstaphopain A protein, Staphylococcus aureusVirulence Factorschemotaxishost defensehost-pathogen interactionsimmune evasioninnate immunityphagocytosisStaphylococcus aureus

Identifiers

PMID28713774
PMCPMC5491559
OpenAlexW2670533836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.